Sanofi (NASDAQ:SNY) Sees Large Volume Increase

Sanofi (NASDAQ:SNY - Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 2,471,112 shares traded hands during trading, an increase of 37% from the previous session's volume of 1,804,097 shares.The stock last traded at $47.51 and had previously closed at $47.15.

Wall Street Analysts Forecast Growth

SNY has been the subject of a number of analyst reports. Morgan Stanley initiated coverage on Sanofi in a research note on Tuesday, January 23rd. They set an "equal weight" rating and a $55.00 target price for the company. TheStreet downgraded Sanofi from a "b" rating to a "c" rating in a research note on Friday, February 9th. Finally, StockNews.com downgraded Sanofi from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, February 27th. One analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Sanofi presently has an average rating of "Hold" and a consensus target price of $55.00.

Sanofi Trading Up 0.8 %

The firm has a market cap of $120.23 billion, a price-to-earnings ratio of 20.14, a PEG ratio of 1.75 and a beta of 0.61. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.87 and a current ratio of 1.27. The business has a fifty day moving average of $47.72 and a two-hundred day moving average of $48.96.

Sanofi (NASDAQ:SNY - Get Free Report) last announced its earnings results on Thursday, February 1st. The company reported $0.89 EPS for the quarter, missing analysts' consensus estimates of $0.94 by ($0.05). The company had revenue of $11.76 billion for the quarter, compared to analyst estimates of $13.02 billion. Sanofi had a net margin of 12.56% and a return on equity of 27.47%. As a group, equities analysts expect that Sanofi will post 4.19 earnings per share for the current fiscal year.

Sanofi Increases Dividend

The business also recently announced an annual dividend, which will be paid on Thursday, June 6th. Shareholders of record on Friday, May 10th will be issued a dividend of $1.478 per share. This represents a yield of 2.98%. The ex-dividend date of this dividend is Thursday, May 9th. This is a boost from Sanofi's previous annual dividend of $1.38. Sanofi's dividend payout ratio is 58.47%.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in SNY. Rise Advisors LLC lifted its stake in shares of Sanofi by 98.4% during the 4th quarter. Rise Advisors LLC now owns 506 shares of the company's stock worth $25,000 after purchasing an additional 251 shares during the period. SRS Capital Advisors Inc. raised its position in shares of Sanofi by 289.1% in the 1st quarter. SRS Capital Advisors Inc. now owns 463 shares of the company's stock worth $25,000 after buying an additional 344 shares during the period. Householder Group Estate & Retirement Specialist LLC purchased a new position in shares of Sanofi in the 3rd quarter worth $26,000. Fairfield Bush & CO. purchased a new position in shares of Sanofi in the 1st quarter worth $26,000. Finally, Indiana Trust & Investment Management CO purchased a new position in shares of Sanofi in the 3rd quarter worth $27,000. Hedge funds and other institutional investors own 10.04% of the company's stock.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.